Prenetics Global Limited (NASDAQ: PRE) announced that its Board of Directors has approved a $40 million share‑repurchase program, allowing the company to buy back shares from the open market over an unspecified period. The program is intended to return capital to shareholders and support the share price as the company continues to focus on its consumer wellness platform.
Continue reading for full analysis...
Prenetics Global Limited announced the launch of its new Daily Ultimate Essentials PRO supplement, a clinical‑grade version of the original Daily Ultimate Essentials, as part of its IM8 wellness brand. The product is marketed as a daily multivitamin that targets the 12 hallmarks of aging, building on the company’s genetics‑backed wellness narrative.
Continue reading for full analysis...
Prenetics Global Limited reported full‑year 2025 revenue of $92.4 million, a 480 % year‑over‑year increase from $15.9 million in FY 2024. The surge is almost entirely driven by the IM8 consumer‑health brand, which generated $60.1 million in revenue and achieved an annualized recurring revenue of roughly $120 million, surpassing $100 million in ARR within just 11 months of launch.
Continue reading for full analysis...
Prenetics Global Limited completed the sale of its 35 % equity interest in Insighta to Tencent on February 13 2026, a transaction announced on February 17 2026. The deal generated $70 million in cash consideration, of which $69 million was received immediately and $1 million was held in escrow.
Continue reading for full analysis...